A continuous delivery system of IL‐1 receptor antagonist reduces angiogenesis and inhibits tumor development-Reference-Cited by-同舟云学术

A continuous delivery system of IL‐1 receptor antagonist reduces angiogenesis and inhibits tumor development

Published:2003-11-03 Issue:1 Volume:18 Page:161-163
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Bar Dganit¹,Apte Ron N.²,Voronov Elena²,Dinarello Charles A.³,Cohen Smadar¹

Affiliation:

1. Department of Biotechnology Engineering and The Institute for Applied Biosciences, Faculty of Engineering SciencesBen‐Gurion University of the Negev Beer‐Sheva 84105 Israel

2. Dept of Microbiology and Immunology and The Cancer Center, Faculty of Health SciencesBen‐Gurion University of the Negev Beer‐ Sheva 84105 Israel

3. University of Colorado, Health Science Center Denver 80262 USA

Funder

Association for International Cancer Research

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.03-0483fje

Reference22 articles.

1. Biologic basis for interleukin-1 in disease

2. Interleukin-1—a major pleiotropic cytokine in tumor–host interactions

3. IL‐1 induced augmentation of experimental metastases from a human melanoma in nude mice;Giavazzi R.;Cancer Res.,1990

4. Interleukin‐1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases;Vidal‐Vanaclocha F.;Cancer Res.,1994

5. Interleukin 1 (IL-1)-Dependent Melanoma Hepatic Metastasis In Vivo; Increased Endothelial Adherence by IL-1-Induced Mannose Receptors and Growth Factor Production In Vitro

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytokines as Potential Therapeutic Targets and their Role in the Diagnosis and Prediction of Cancers;Current Pharmaceutical Design;2023-09

2. IL-1RA inhibits esophageal carcinogenesis and lymphangiogenesis via downregulating VEGF-C and MMP9;Functional & Integrative Genomics;2023-05-18

3. Interleukin-1 receptor antagonist: a promising cytokine against human squamous cell carcinomas;Heliyon;2023-04

4. Chemokine and Cytokine Network in Angiogenesis;Cytokine and Chemokine Networks in Cancer;2023

5. Role of Cytokines and Chemokines in Angiogenesis in a Tumor Context;Cancers;2022-05-16